Brief: Aker BioMarine Q1 Adj. EBITDA at USD 6 Million
Apr 28 (Reuters) - Aker BioMarine Q1 adjusted EBITDA USD 6 million. * Q1 revenue USD 69 million * Expects long-term average annual sales growth in line with earlier communicated ambitions at around 15%
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million